U
Imagenetix, Inc. IAGX
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

Imagenetix, Inc. (formerly traded under the ticker IAGX) was a U.S.-based health and wellness company focused on nutraceuticals, dietary supplements, and condition-specific consumer health products. The company operated within the broader consumer healthcare and nutritional supplement industries, with product development centered on formulations intended to support cardiovascular health, joint health, vision care, and overall wellness. Public disclosures and historical filings indicate that revenue generation was tied primarily to branded supplement sales, licensing arrangements, and distribution partnerships.

The company evolved through a combination of internal product development and acquisitions in the nutraceutical sector. Historical corporate records and archived public filings indicate that Imagenetix pursued a strategy of building proprietary formulations and leveraging scientific marketing claims tied to ingredients such as plant sterols, omega-based compounds, and antioxidant blends. Data regarding current operations, active exchange listings, and present-day financial performance is inconclusive based on available public sources.

Business Operations

Imagenetix historically operated through consumer health and nutritional supplement activities rather than diversified industrial segments. Its business model focused on developing, marketing, and distributing branded dietary supplements through retail, wholesale, and healthcare-related channels. Publicly available information indicates the company controlled intellectual property related to supplement formulations and maintained relationships with manufacturers and distributors supporting commercialization efforts.

The company’s operations appear to have been primarily concentrated in the United States, though some products were marketed internationally through distribution arrangements. Historical references in company filings and financial databases mention strategic relationships within the nutritional products industry, but detailed and consistently verified information regarding major long-term joint ventures, active subsidiaries, or material international operating divisions is limited. Data inconclusive based on available public sources.

Strategic Position & Investments

Imagenetix positioned itself within the growing preventive healthcare and wellness market, emphasizing scientifically supported nutritional ingredients and targeted health formulations. Its strategic direction historically focused on expanding product portfolios, increasing retail distribution, and strengthening intellectual property around specialty nutraceutical compounds. Company materials and historical market coverage suggest management sought differentiation through condition-specific health products rather than broad commodity supplement offerings.

The company also pursued acquisitions and licensing opportunities as part of its growth strategy. Historical public records reference activity involving branded supplement assets and proprietary formulations, although complete and consistently verified details regarding the scale and long-term financial impact of these investments remain limited. There is insufficient publicly available current data confirming ongoing investment activity, emerging technology initiatives, or active portfolio subsidiaries associated with Imagenetix.

Geographic Footprint

Imagenetix maintained its primary operational presence in the United States, where its headquarters and principal commercial activities were historically based. Its products were marketed mainly to North American consumers through retail and distribution networks tied to the dietary supplement and consumer wellness sectors.

Available public information suggests limited international exposure through distribution relationships rather than extensive owned foreign operations. There is no consistently verified evidence from recent public filings indicating a substantial multinational operational footprint across Europe, Asia-Pacific, or Latin America. Data regarding current international operations is inconclusive based on available public sources.

Leadership & Governance

Historical leadership information for Imagenetix is fragmented because of limited recent reporting activity and reduced public disclosures. Earlier corporate filings and market references indicate that the company was managed by executives with backgrounds in consumer healthcare, nutraceuticals, and product commercialization. Strategic messaging historically emphasized growth through branded health products, intellectual property development, and expansion into preventive wellness categories.

Known historical executives identified in public records include:

  • Stephen W. Glasgow – Former Chief Executive Officer
  • William Spencer – Former executive leadership role referenced in historical company materials
  • R. Kerry Griswold – Former executive and board-related leadership role referenced in archived filings

Current executive leadership, governance structure, and board composition could not be conclusively verified from available recent public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $224.41
B
AAPL NASDAQ $324.96
B
AVGO NASDAQ $367.24
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $106.09
Top Financial Stocks
See All »
B
B
JPM NYSE $356.22
B
V NYSE $378.40
Top Health Care Stocks
See All »
B
LLY NYSE $1,160.08
B
JNJ NYSE $275.21
B
ABBV NYSE $261.72
Top Real Estate Stocks
See All »
B
PLD NYSE $136.59
B
EQIX NASDAQ $1,019.24